Prognostic importance of the fusion partners and measurable residual disease in patients with acute myeloid leukemia who harbor 11q23/KMT2A alterations.

ABSTRACT:

SUBMITTER: Mrozek K 

PROVIDER: S-EPMC10644025 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature